SCHEMBL24695844

SCHEMBL24695844

CCOC(=O)c1cc2nc(CC3CCC(C)(C)CC3)cc(O)n2n1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.38
▸ POLB P06746 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KMT2A Q03164 2/20 0.35
▸ ADORA3 P0DMS8 1/20 0.34
▸ AKT1 P31749 1/20 0.33
▸ AKT2 P31751 1/20 0.33
▸ OGFRL1 Q5TC84 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ TBK1 Q9UHD2 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ FAAH O00519 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24696347 0.89 KDM4E (0.40) KDM4EPOLBALDH1A1HPGDKMT2A
SCHEMBL24695633 0.89 KDM4E (0.40) KDM4EPOLBALDH1A1HPGDKMT2A
SCHEMBL24695841 0.89 KDM4E (0.37) KDM4EPOLBALDH1A1HPGDKMT2A
SCHEMBL24695628 0.89 SMN1; SMN2 (0.41) KDM4EPOLBALDH1A1HPGDKMT2A
SCHEMBL24695972 0.89 SMN1; SMN2 (0.41) KDM4EPOLBALDH1A1HPGDKMT2A
SCHEMBL24696140 0.89 KDM4E (0.39) KDM4EPOLBALDH1A1HPGDKMT2A
SCHEMBL24695976 0.88 HPGD (0.39) KDM4EPOLBALDH1A1HPGDKMT2A
SCHEMBL24695846 0.87 KDM4E (0.36) KDM4EPOLBALDH1A1HPGDKMT2A
SCHEMBL24696246 0.87 KDM4E (0.40) KDM4EPOLBALDH1A1HPGDKMT2A
SCHEMBL24695843 0.86 KDM4E (0.35) KDM4EPOLBALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022255408-A1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-12-08 — — WO disclosed
Send feedback